Evidence map›Paper›PMID 27725188›Full record

ArticleToxicology and applied pharmacology2016

Omeprazole induces heme oxygenase-1 in fetal human pulmonary microvascular endothelial cells via hydrogen peroxide-independent Nrf2 signaling pathway.

Ananddeep Patel, Shaojie Zhang, Amrit Kumar Shrestha, Paramahamsa Maturu, Bhagavatula Moorthy, Binoy Shivanna

Abstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ananddeep PatelDivision of Neonatal-Perinatal Medicine, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States.
Shaojie ZhangDivision of Neonatal-Perinatal Medicine, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States.
Amrit Kumar ShresthaDivision of Neonatal-Perinatal Medicine, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States.
Paramahamsa MaturuDivision of Neonatal-Perinatal Medicine, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States.
Bhagavatula MoorthyDivision of Neonatal-Perinatal Medicine, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States.
Binoy ShivannaDivision of Neonatal-Perinatal Medicine, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States. Electronic address: shivanna@bcm.edu.
Texas Children's Hospital · US

Funding

MOLECULAR MECHANISMS OF CYTOCHROME P4501A1 EXPRESSIONR01ES009132 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI MOORTHY, BHAGAVATULA · 1998 to 2017
$3.8M
Functional roles of Nrf2 and NQO1 genetic variants in hyperoxic lung injury-ARDSR01HL112516 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MOORTHY, BHAGAVATULA · 2012 to 2016
$2.9M
Supplement2: Mechanistic Roles of Cytochrome P4501A Enzymes in Hyperoxic Lung InjuryR01HL129794 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MOORTHY, BHAGAVATULA · 2016 to 2019
$2.2M
Role of cytochrome P4501B1 in oxygen-mediated pulmonary injuryR01ES019689 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI MOORTHY, BHAGAVATULA · 2011 to 2015
$2.1M
Roles of pulmonary and hepatic P4501A enzymes in hyperoxic lung injury in miceR01HL087174 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MOORTHY, BHAGAVATULA · 2007 to 2010
$1.5M
Modulation of Neonatal Hyperoxic Lung Injury by the Aryl Hydrocarbon ReceptorK08HD073323 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI SHIVANNA, BINOY · 2013 to 2017
$649k
NHLBI NIH HHS R01 HL087174NHLBI NIH HHS R01 HL112516NHLBI NIH HHS R01 HL129794NICHD NIH HHS K08 HD073323NIEHS NIH HHS R01 ES009132NIEHS NIH HHS R01 ES019689
6 · The paper itself

Abstract

Omeprazole (OM) is an aryl hydrocarbon receptor (AhR) agonist and a proton pump inhibitor that is used to treat humans with gastric acid related disorders. Recently, we showed that OM induces NAD (P) H quinone oxidoreductase-1 (NQO1) via nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent mechanism. Heme oxygenase-1 (HO-1) is another cytoprotective and antioxidant enzyme that is regulated by Nrf2. Whether OM induces HO-1 in fetal human pulmonary microvascular endothelial cells (HPMEC) is unknown. Therefore, we tested the hypothesis that OM will induce HO-1 expression via Nrf2 in HPMEC. OM induced HO-1 mRNA and protein expression in a dose-dependent manner. siRNA-mediated knockdown of AhR failed to abrogate, whereas knockdown of Nrf2 abrogated HO-1 induction by OM. To identify the underlying molecular mechanisms, we determined the effects of OM on cellular hydrogen peroxide (H

Indexed as

Signal TransductionCells, CulturedEndothelium, VascularHeme Oxygenase-1HumansHydrogen PeroxideLungMicrovesselsNF-E2-Related Factor 2OmeprazoleHeme Oxygenase-1Hydrogen PeroxideNFE2L2 protein, humanNF-E2-Related Factor 2OmeprazoleAryl hydrocarbon receptorFetal human pulmonary microvascular endothelial cellsHeme oxygenase-1Hydrogen peroxideNuclear factor erythroid 2-related factor 2Omeprazole

Identifiers

PMID27725188
PMCPMC5089963
OpenAlexW2531378150

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.